ArticleCureus2026
Sweet Syndrome in a Patient With Acute Myeloid Leukemia: A Diagnostic Challenge in the Setting of Chemotherapy-Induced Neutropenia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 69-year-old male with acute myeloid leukemia (AML) undergoing chemotherapy developed erythematous skin lesions at sites of prior intravenous access, along with fever and elevated inflammatory markers. Initially suspected of having resistant cellulitis or disseminated infection, his condition did not improve despite broad-spectrum antibiotics. Skin biopsy confirmed Sweet syndrome, and the patient showed rapid clinical improvement following corticosteroid therapy, with resolution of fever and skin lesions within 72 hours. This case underscores the importance of considering Sweet syndrome in neutropenic patients with unexplained fever and skin lesions, as early recognition and treatment can prevent unnecessary antibiotic use and ensure timely continuation of chemotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.